4.4 Article

Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose

Journal

OPEN FORUM INFECTIOUS DISEASES
Volume 7, Issue 11, Pages -

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofaa505

Keywords

antibody response; humoral immunity; measles; mumps; rubella; seroprotection; vaccine; waning

Funding

  1. Dutch Ministry of Health, Welfare and Sport

Ask authors/readers for more resources

Background. Breakthrough infections of measles and mumps have raised concerns about the duration of vaccine-induced immunity, which might be improved by a third dose of measles-mumps-rubella vaccine (MMR3). Methods. Here we compared (IgG) antibody levels against measles, mumps, and rubella in blood samples of 9-year-old children and young adults (18-25 years) following MMR2 and MMR3, respectively. Results. We found that, in addition to antibody boosting for all 3 vaccine components, MMR3 resulted in lower antibody decay rates than MMR2; the declines were most prominent for mumps and rubella. Conclusions. This study suggests that MMR3 provides long-lasting seroprotection against measles, mumps, and rubella.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available